Treatment of Streptococcus agalactiae (Group B Streptococcus) in Urine
For Group B Streptococcus (GBS) in urine, treatment should be provided for pregnant women at any concentration, while in non-pregnant adults, treatment is only indicated for symptomatic infections or colony counts ≥100,000 CFU/mL. 1
Treatment Approach Based on Patient Population
Pregnant Women
- All GBS bacteriuria during pregnancy requires treatment regardless of colony count or symptoms 1
- First-line treatment options:
- Amoxicillin-clavulanic acid
- Nitrofurantoin
- Sulfamethoxazole-trimethoprim 1
- Important: Pregnant women with GBS bacteriuria at any point during pregnancy will also require intrapartum antibiotic prophylaxis (IAP) during labor 1
Non-Pregnant Adults
- Treatment indicated only if:
- Patient is symptomatic OR
- Colony count ≥100,000 CFU/mL 1
- Colony counts of 10,000-49,000 CFU/mL without symptoms should not be treated 1
- More aggressive treatment approach should be considered in high-risk groups:
- Patients with urinary tract abnormalities
- Patients with chronic renal failure 1
Antibiotic Selection
First-Line Options
- Amoxicillin-clavulanic acid
- Nitrofurantoin
- Sulfamethoxazole-trimethoprim 1
- Penicillin G (all isolates remain fully susceptible) 2, 3, 4
Alternative Options (for penicillin-allergic patients)
- Check susceptibility testing before using alternatives due to increasing resistance patterns:
Special Considerations for UTI Treatment
- Nitrofurantoin is specifically recommended for GBS bacteriuria treatment 4
- Fluoroquinolones (ciprofloxacin, ofloxacin) should be reserved for pyelonephritis or severe cases 1, 4
- Broad-spectrum antibiotics like carbapenems should be avoided unless multidrug resistance is confirmed 1
Intrapartum Antibiotic Prophylaxis for Pregnant Women
For pregnant women who had GBS bacteriuria at any point during pregnancy, IAP is required during labor with the following regimens:
First-Line IAP Regimen
- Penicillin G: 5 million units IV initial dose, then 2.5-3.0 million units IV every 4 hours until delivery 1, 5
- Note: Research supports that the dosing interval should be 4 hours to ensure anti-GBS activity 5
Alternative IAP Regimens
- Ampicillin: 2 g IV initial dose, then 1 g IV every 4 hours until delivery 1
- Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours until delivery (for penicillin-allergic patients without anaphylaxis) 1
- Clindamycin: Only if GBS isolate is tested and susceptible (for patients with severe penicillin allergy) 1
Important Clinical Pearls
- Treating GBS colonization with oral antibiotics in the third trimester does not eliminate GBS from the genitourinary tract; recolonization after treatment is common 1
- IAP is most effective when administered at least 4 hours before delivery 1
- Local antibiotic resistance patterns should be considered when selecting antibiotics 1, 2, 3
- The macrolide-lincosamide-streptogramin B (MLSB) phenomenon has been noted in some GBS isolates, which can affect treatment efficacy 2
- Pregnant women should be screened for GBS colonization at 36 0/7 to 37 6/7 weeks of gestation with vaginal-rectal cultures 1
- Increasing resistance to macrolides and clindamycin has been reported, highlighting the importance of susceptibility testing 3, 4
Common Pitfalls to Avoid
- Do not treat asymptomatic bacteriuria with colony counts <100,000 CFU/mL in non-pregnant adults 1
- Do not use antibiotics before the intrapartum period to eradicate GBS genitorectal colonization in pregnant women 1
- Do not assume all GBS isolates are susceptible to macrolides or clindamycin without susceptibility testing 1, 2, 3, 4
- Do not discontinue breastfeeding for mothers with GBS infection who are receiving appropriate antibiotic treatment 1